Zobrazeno 1 - 10
of 61
pro vyhledávání: '"K, Rosenlöf"'
Publikováno v:
Clinical Nephrology. 58:85-94
Background: A number of factors are linked to the outcome of IgA nephropathy (IgAN). However, it has been difficult to compare results of studies since patient populations have varied greatly. There were 3 aims in the study reported here, namely to c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b10f24df3af8078f191139cf0f2d1d64
https://doi.org/10.5414/cnp58085
https://doi.org/10.5414/cnp58085
Publikováno v:
Acta ophthalmologica Scandinavica. 77(2)
To describe the incidence and type of ocular findings of 34 patients with Alport syndrome and to analyze the association of gene defect in COL4A5 gene to ocular abnormalities found.A nationwide search of Alport syndrome patients was performed in Finl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9c59b1e79ab4987471bc8171264084f5
https://pubmed.ncbi.nlm.nih.gov/10321542
https://pubmed.ncbi.nlm.nih.gov/10321542
Publikováno v:
Clinical nephrology. 43(4)
Iron deficiency is common in hemodialysis patients, particularly if they are on recombinant human erythropoietin (rHuEPO) therapy. Ten anemic patients (hemoglobin concentration 89 +/- 2.2 g/l, mean +/- SEM) on hemodialysis with either storage (serum-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4d3d8b53daea41dfc9d1875b3c7dfe8e
https://pubmed.ncbi.nlm.nih.gov/8616962
https://pubmed.ncbi.nlm.nih.gov/8616962
Autor:
K, Rosenlöf
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 111(15)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ef64bc22e9b737856254719807b43a66
https://pubmed.ncbi.nlm.nih.gov/9244705
https://pubmed.ncbi.nlm.nih.gov/9244705
Publikováno v:
British journal of rheumatology. 33(6)
The effect of recombinant human erythropoietin (rHuEPO) on haem biosynthesis in peripheral red blood cells was evaluated in 12 patients with RA and anaemia (mean haemoglobin concentration 102 g/l, range 90-109 g/l). Before treatment, the serum concen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::776e7370f7a6c173796beaa6038ff789
https://pubmed.ncbi.nlm.nih.gov/8205399
https://pubmed.ncbi.nlm.nih.gov/8205399
Publikováno v:
Scandinavian journal of rheumatology. 22(4)
We performed a 24-week open clinical study in which 12 patients with rheumatoid arthritis (RA) and anemia (mean hemoglobin (Hb) value 102 g/l, range 90–109 g/l) were treated with recombinant human erythropoietin (rHuEPO). rHuEPO was given as a subc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54260f0d7b5c729d9eda0fde6dbbd99d
https://pubmed.ncbi.nlm.nih.gov/8356412
https://pubmed.ncbi.nlm.nih.gov/8356412
Autor:
K, Rosenlöf, E, Honkanen
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 107(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::762ab1597649180584807de57c3461dc
https://pubmed.ncbi.nlm.nih.gov/1364734
https://pubmed.ncbi.nlm.nih.gov/1364734
Publikováno v:
Lancet (London, England). 335(8684)
Effects of erythropoietin treatment on haem synthesis in peripheral blood were evaluated in 11 patients on haemodialysis. After 2 weeks of erythropoietin, mean (SEM) uroporphyrinogen-I synthase activity increased significantly from 88 (10) to 116 (9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e829e2f1dbaa005c4efa339f7b7dfcc
https://pubmed.ncbi.nlm.nih.gov/1973809
https://pubmed.ncbi.nlm.nih.gov/1973809
Autor:
Eero Honkanen, K. Rosenlöf, Carola Grönhagen-Riska, Anssi Sovijärvi, P. Piirilä, Frej Fyhrquist, Ilkka Tikkanen, Agneta Ekstrand
Publikováno v:
Journal of Internal Medicine. 226:311-317
Rosenlof K, Gronhagen-Riska C, Sovijarvi A, Honkanen E, Tikkanen I, Ekstrand A, Piirila P, Fyhrquist F (IV Department of Internal Medicine, and Department of Pulmonary Medicine. Helsinki University Central Hospital. Finland). Beneficial effects of er
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aaecce2fdaeedd628f0b9b94d1a060f
https://doi.org/10.1111/j.1365-2796.1989.tb01401.x
https://doi.org/10.1111/j.1365-2796.1989.tb01401.x
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 47:823-827
Human recombinant erythropoietin, labelled with 125I, was saturably bound to high affinity receptors, ka = 1.5 X 10(9) M-1, of bone marrow cells from 10 patients with various haematological disorders. Binding of labelled erythropoietin was specific,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08c90fc7353eb049b5a6fee2eb2c1f4e
https://doi.org/10.3109/00365518709168952
https://doi.org/10.3109/00365518709168952